U.S. Tech Hardware Stock News

NasdaqGM:CSTL
NasdaqGM:CSTLHealthcare

Castle Biosciences (CSTL) Q4 EPS Loss Tests Bullish Profitability Narrative

Castle Biosciences (CSTL) has wrapped up FY 2025 with Q4 revenue of US$87 million and a basic EPS loss of US$0.08, alongside trailing twelve month revenue of US$344.2 million and a basic EPS loss of US$0.83. Over recent periods, the company has seen quarterly revenue range from US$83 million to US$88 million, while basic EPS has moved between a loss of US$0.90 and a profit of US$0.16. This sets the stage for investors to focus closely on how those revenue levels translate into sustainable...
NYSE:GWW
NYSE:GWWTrade Distributors

Assessing W.W. Grainger (GWW) Valuation After Its Better Than Expected Earnings And Upgraded Outlook

What the latest earnings mean for W.W. Grainger (GWW) investors W.W. Grainger (GWW) recently posted quarterly results that topped expectations on both earnings and revenue, while management laid out full year guidance that points to higher projected EPS and sales compared with its latest reported figures. See our latest analysis for W.W. Grainger. At a share price of $1,144.73, W.W. Grainger has seen a 20.67% 90 day share price return and a 68.51% three year total shareholder return,...
NYSE:FIGS
NYSE:FIGSLuxury

FIGS (FIGS) Margin Rebound Reinforces Bullish Narratives Despite Premium 75.1x P/E

FIGS (FIGS) closed out FY 2025 with Q4 revenue of US$201.9 million and basic EPS of US$0.11, while trailing twelve month EPS sat at US$0.21 on US$631.1 million of revenue. This came alongside a very large year over year earnings increase and a trailing net profit margin of 5.4% versus 0.5% a year earlier. The company has seen quarterly revenue move from US$151.8 million and EPS of US$0.01 in Q4 2024 to US$201.9 million and EPS of US$0.11 in Q4 2025, putting improving profitability front and...
NYSE:WD
NYSE:WDDiversified Financial

Walker & Dunlop (WD) One Off Loss And Margin Compression Test Bullish Growth Narratives

Walker & Dunlop FY 2025 earnings snapshot Walker & Dunlop (WD) closed out FY 2025 with Q4 revenue of US$320.9 million and a basic EPS loss of US$0.39, as net income excluding extra items came in at a loss of US$13.1 million. The company reported quarterly revenue of US$321.0 million and EPS of US$1.32 in Q4 2024, compared with US$320.9 million and an EPS loss of US$0.39 in Q4 2025. Trailing twelve month revenue was US$1.2 billion and basic EPS was US$1.71. With margins under pressure and a...
NasdaqGS:ALHC
NasdaqGS:ALHCHealthcare

Alignment Healthcare (ALHC) Near Breakeven TTM Loss Tests Bullish Profitability Narratives

Alignment Healthcare (ALHC) has wrapped up FY 2025 with Q4 revenue of US$1.0b and a basic EPS loss of US$0.05, alongside trailing 12 month revenue of US$4.0b and a near breakeven basic EPS of US$0.00. The company has seen quarterly revenue move from US$701.2m and a basic EPS loss of US$0.16 in Q4 2024 to US$1.0b and a basic EPS loss of US$0.05 in Q4 2025, while trailing 12 month basic EPS shifted from a loss of US$0.67 in Q4 2024 to a small loss of US$0.00 in Q4 2025, putting the focus firmly...
NasdaqGS:CTKB
NasdaqGS:CTKBLife Sciences

Cytek Biosciences (CTKB) Q4 EPS Swing To Loss Reinforces Margin Concerns

Cytek Biosciences (CTKB) closed out FY 2025 with Q4 revenue of US$62.1 million and a basic EPS loss of US$0.34, as net income excluding extra items came in at a loss of US$44.1 million. The company has seen quarterly revenue range from US$41.5 million to US$62.1 million over the past year, while basic EPS moved from a profit of US$0.07 in Q4 2024 to a loss of US$0.34 in Q4 2025. This shift highlights a clear pressure point on profitability. For investors, the latest print keeps the focus...
NasdaqCM:RIOT
NasdaqCM:RIOTSoftware

Riot Platforms Earnings Beat Fuels Debate On Crypto Versus Operations

Riot Platforms reported revenues that exceeded consensus estimates. The company delivered an earnings surprise relative to market expectations. The results highlight operational performance that goes beyond price driven speculation. Riot Platforms, trading under NasdaqCM:RIOT, is drawing attention after its latest results, with revenue and earnings both coming in ahead of what the market had been expecting. The stock closed at $16.29, with a return of 15.0% year to date and 75.5% over the...
NasdaqGS:TRS
NasdaqGS:TRSPackaging

TriMas (TRS) Margin Jump Driven By One Off Gains Challenges Earnings Quality Narratives

TriMas (TRS) has wrapped up FY 2025 with fourth quarter revenue of US$155.5 million and basic EPS of US$1.84, while trailing twelve month EPS stands at US$1.79 on revenue of US$645.7 million and a net profit margin of 11.2% versus 2.6% a year earlier. Over recent periods, the company has seen quarterly revenue range from US$228.1 million in Q4 2024 to US$274.8 million in Q2 2025, with basic EPS moving from US$0.14 in Q4 2024 to US$0.41 in Q2 2025 and US$0.31 in Q1 2025. With earnings over the...
NYSE:XPOF
NYSE:XPOFHospitality

Xponential Fitness (XPOF) Q4 Loss Widening Tests Bullish Margin Recovery Narratives

Xponential Fitness (XPOF) just wrapped up FY 2025 with Q4 revenue of US$83.0 million, a basic EPS loss of US$0.93 and net income excluding extra items showing a loss of US$32.9 million. Over the past six quarters, the company has seen quarterly revenue move between US$76.2 million and US$83.8 million, while basic EPS ranged from a loss of US$0.01 to a loss of US$1.37. Trailing twelve month EPS stands at a loss of US$1.11 on revenue of US$314.9 million and a net loss excluding extra items of...
NasdaqCM:RKLB
NasdaqCM:RKLBAerospace & Defense

Rocket Lab (RKLB) Q4 Loss Of US$52.9 Million Tests Profitability Narratives

Rocket Lab (RKLB) has just put fresh numbers on the table for FY 2025, reporting Q4 revenue of US$179.7 million and a basic EPS loss of US$0.09, alongside trailing 12 month revenue of US$601.8 million and a full year EPS loss of US$0.37. The company’s quarterly revenue moved from US$132.4 million in Q4 2024 to US$179.7 million in Q4 2025, while quarterly EPS losses ranged between US$0.10 and US$0.13 across FY 2025. As a result, the focus for investors is on how quickly those losses can be...
NasdaqGM:OCUL
NasdaqGM:OCULPharmaceuticals

Is Ocular Therapeutix (OCUL) Pricing Reflecting Its Recent Volatility And DCF Implied Upside

Investors may be wondering whether Ocular Therapeutix at US$8.94 is starting to look interesting on price, or if the recent moves are already baking in the upside. The stock has been volatile lately, with a 14.9% gain over the last 7 days, a 13.0% decline over 30 days, a 24.4% decline year to date, a 25.2% return over 1 year, and 51.3% over 3 years, while still sitting 51.7% lower over 5 years. These swings have kept Ocular Therapeutix on the radar of investors watching for changing...
NasdaqGS:ICFI
NasdaqGS:ICFIProfessional Services

ICF International (ICFI) Margin Compression Challenges Long Term EPS Growth Narrative

ICF International (ICFI) closed out FY 2025 with Q4 revenue of US$443.7 million and basic EPS of US$0.95, alongside trailing twelve month revenue of about US$1.9 billion and EPS of US$5.0 that frame the latest print against a full year backdrop. Over recent quarters, the company has seen revenue move from US$516.9 million in Q3 2024 to US$487.6 million in Q1 2025 and US$443.7 million in Q4 2025, while basic EPS shifted from US$1.74 to US$1.45 and then to US$0.95. This sets up a results season...
NasdaqGS:GSAT
NasdaqGS:GSATTelecom

Globalstar (GSAT) Losses Narrow Sharply Which Reinforces Bullish Profitability Narratives

Globalstar (GSAT) has released its FY 2025 numbers, reporting Q4 revenue of US$72 million and a basic EPS loss of US$0.11. On a trailing twelve month basis, revenue came in at US$273 million and basic EPS was a loss of US$0.15. Over recent periods, the company has seen quarterly revenue range from US$60 million to US$74 million and basic EPS swing between a profit of US$0.13 and losses of up to US$0.42. This gives a clear view of how volatile margins have been as the business works through...
NYSE:CON
NYSE:CONHealthcare

Concentra Group (CON) Margin Compression Challenges Bullish Earnings Growth Narrative

Concentra Group Holdings Parent FY 2025 earnings snapshot Concentra Group Holdings Parent (CON) has wrapped up FY 2025 with Q4 revenue of US$539.1 million and basic EPS of US$0.28, capping off a year where trailing 12 month revenue reached about US$2.2 billion and EPS sat at US$1.30. The company has seen quarterly revenue move from US$465.0 million in Q4 2024 to US$539.1 million in Q4 2025, while basic EPS over that same Q4 stretch shifted from US$0.17 to US$0.28, setting up a situation where...
NYSE:BX
NYSE:BXCapital Markets

Is Blackstone (BX) Now Offering Value After Its Recent Share Price Pullback?

If you are wondering whether Blackstone is starting to look interesting at today's price, this article will walk through what the current market tag might be implying about its long term value. After reaching a last close of US$113.37, the stock has seen a 6.5% decline over the past week and a 22.8% decline over the past month, while still sitting on gains of 36.4% over 3 years and 103.7% over 5 years. Recent attention on Blackstone has been shaped by ongoing headlines around private...
NYSE:RLJ
NYSE:RLJHotel and Resort REITs

RLJ Lodging Trust (RLJ) FFO Volatility Tests Bullish Earnings Growth Narrative

RLJ Lodging Trust (RLJ) closed out FY 2025 with fourth quarter revenue of US$328.6 million and basic EPS of a US$0.04 loss, while the trailing twelve months show revenue of about US$1.35 billion and basic EPS of roughly a US$0.02 profit. Over recent periods, the company has seen quarterly revenue move in a tight band around the US$328 million to US$363 million range and basic EPS swing between a loss of about US$0.07 and a profit of roughly US$0.15. This leaves investors weighing modest top...
NYSE:NEXA
NYSE:NEXAMetals and Mining

Nexa Resources (NEXA) TTM Return To Profit Tests Bullish Margin Narratives

Nexa Resources (NYSE:NEXA) has wrapped up FY 2025 with fourth quarter revenue of US$903.0 million and basic EPS of US$0.38, setting a clear marker for how the year finished. The company has seen quarterly revenue range from US$627.1 million in Q1 2025 to US$903.0 million in Q4 2025, while basic EPS moved from US$0.09 in Q1 to US$0.52 in Q3 and US$0.38 in Q4, giving investors a fuller picture of how profitability has tracked alongside sales. With trailing twelve month EPS at US$1.00 and net...
NYSE:MPT
NYSE:MPTHealth Care REITs

FFO Recovery At Medical Properties Trust (MPW) Challenges Bearish Cash Flow Narratives

Latest Earnings Snapshot Medical Properties Trust (MPW) has wrapped up FY 2025 with fourth quarter revenue of US$294.5 million, basic EPS of US$0.03, and Funds From Operations of US$115.9 million, giving investors a cleaner read on cash based performance for a healthcare REIT. The company has seen revenue move from US$247.5 million in Q3 2024 to US$234.8 million in Q4 2024 and then to US$294.5 million in Q4 2025. Basic EPS shifted from a loss of US$0.69 in Q4 2024 to a loss of US$0.20 in Q1...
NYSE:IBM
NYSE:IBMIT

Reassessing IBM (IBM) Valuation After Recent Share Price Pullback

If you are looking at International Business Machines and wondering whether the recent price gives you a fair entry point, you will want to see how its current market value stacks up against a few different valuation yardsticks. IBM shares last closed at US$240.21, with returns of 6.6% decline over 7 days, 18.3% decline over 30 days, 17.6% decline year to date, 2.5% decline over 1 year, 105.4% over 3 years and 149.9% over 5 years. These moves may have shifted how the market is pricing its...
NasdaqCM:LQDA
NasdaqCM:LQDAPharmaceuticals

Assessing Liquidia (LQDA) Valuation After Recent Share Price Volatility And YUTREPIA Growth Expectations

Event context and recent share performance Liquidia (LQDA) has drawn investor attention after recent share price swings, with the stock rising about 0.8% over the past day but recording a 7.6% decline over the past week. Those short term moves sit alongside a month drop of about 26% and a past 3 months decline of roughly 4.9%. This puts the current share price of US$31.03 in a different context than longer term total returns. See our latest analysis for Liquidia. Zooming out, Liquidia’s...
NasdaqGS:MMYT
NasdaqGS:MMYTHospitality

The Bull Case For MakeMyTrip (MMYT) Could Change Following OpenAI-Powered Myra Travel Integration – Learn Why

In February 2026, OpenAI announced a collaboration with MakeMyTrip Limited to power new AI-led travel discovery and booking features within the Myra interface, using OpenAI's APIs to turn conversational queries into structured, transaction-ready options across flights, hotels and ancillary services. This shift places MakeMyTrip directly inside AI-driven travel planning journeys, potentially moving it from passive search exposure to active, intent-driven trip curation and bookings. We’ll now...
NasdaqGM:KIDS
NasdaqGM:KIDSMedical Equipment

OrthoPediatrics (KIDS) Revenue Strength Keeps Profitability Concerns In Spotlight After FY 2025 Results

OrthoPediatrics (KIDS) closed out FY 2025 with Q4 revenue of US$61.6 million, a basic EPS loss of US$0.43 per share and net income excluding extra items of a US$10.1 million loss, while the trailing twelve months showed US$236.3 million in revenue and a US$39.6 million loss. The company has seen quarterly revenue move from US$52.7 million in Q4 2024 to US$61.6 million in Q4 2025, but EPS over that span remained in loss making territory. This sets up an earnings season where investors are...
NasdaqGS:FIP
NasdaqGS:FIPTransportation

FTAI Infrastructure (FIP) Loss Deepens With US$1.02 Q4 EPS Challenging Bullish Narratives

FTAI Infrastructure (FIP) just wrapped up FY 2025 with Q4 revenue of US$143.5 million and a basic EPS loss of US$1.02, while trailing twelve month figures show revenue of US$502.5 million and a basic EPS loss of US$1.80. Over the past six reported quarters, the company has seen revenue move from US$80.8 million in Q4 2024 to US$143.5 million in Q4 2025, alongside quarterly basic EPS swinging between a profit of US$0.95 in Q1 2025 and losses such as US$1.37 in Q3 2025. These latest numbers put...
NYSE:VTEX
NYSE:VTEXIT

VTEX NYSE VTEX Margin Expansion Reinforces Bullish Earnings Narrative After FY 2025 Results

VTEX (NYSE:VTEX) closed out FY 2025 with Q4 revenue of US$68.0 million and basic EPS of US$0.06, alongside net income of US$9.8 million. On a trailing twelve month basis, revenue was US$240.5 million with basic EPS of US$0.11 and net income of US$20.0 million. The company reported quarterly revenue moving from US$54.2 million in Q1 2025 to US$68.0 million in Q4 and basic EPS increasing from US$0.00 in Q1 to US$0.06 in Q4, indicating higher quarterly earnings contributions across the year...